Posterity of nanoscience as lipid nanosystems for Alzheimer's disease regression.
Anti-alzheimer's disease therapy
Lipid nano systems
Nanomedicine
Neurodegenerative diseases
Journal
Materials today. Bio
ISSN: 2590-0064
Titre abrégé: Mater Today Bio
Pays: England
ID NLM: 101757228
Informations de publication
Date de publication:
Aug 2023
Aug 2023
Historique:
received:
18
03
2023
revised:
08
06
2023
accepted:
10
06
2023
medline:
7
7
2023
pubmed:
7
7
2023
entrez:
7
7
2023
Statut:
epublish
Résumé
Alzheimer's disease (AD) is a type of dementia that affects a vast number of people around the world, causing a great deal of misery and death. Evidence reveals a relationship between the presence of soluble Aβ peptide aggregates and the severity of dementia in Alzheimer's patients. The BBB (Blood Brain Barrier) is a key problem in Alzheimer's disease because it prevents therapeutics from reaching the desired places. To address the issue, lipid nanosystems have been employed to deliver therapeutic chemicals for anti-AD therapy in a precise and targeted manner. The applicability and clinical significance of lipid nanosystems to deliver therapeutic chemicals (Galantamine, Nicotinamide, Quercetin, Resveratrol, Curcumin, HUPA, Rapamycin, and Ibuprofen) for anti-AD therapy will be discussed in this review. Furthermore, the clinical implications of the aforementioned therapeutic compounds for anti-AD treatment have been examined. Thus, this review will pave the way for researchers to fashion therodiagnostics approaches based on nanomedicine to overcome the problems of delivering therapeutic molecules across the blood brain barrier (BBB).
Identifiants
pubmed: 37415846
doi: 10.1016/j.mtbio.2023.100701
pii: S2590-0064(23)00161-8
pmc: PMC10320624
doi:
Types de publication
Journal Article
Review
Langues
eng
Pagination
100701Informations de copyright
© 2023 The Authors.
Déclaration de conflit d'intérêts
The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Neurochem. 2002 Oct;83(1):57-66
pubmed: 12358729
Int J Mol Sci. 2022 Dec 30;24(1):
pubmed: 36614120
Chem Biol Interact. 2017 Sep 25;275:61-73
pubmed: 28734741
Front Immunol. 2013 Sep 17;4:282
pubmed: 24062748
Arch Biochem Biophys. 1998 Sep 15;357(2):299-309
pubmed: 9735171
Vaccines (Basel). 2020 Mar 13;8(1):
pubmed: 32183198
J Alzheimers Dis. 2020;74(4):1231-1242
pubmed: 32144987
Ageing Res Rev. 2014 Jan;13:10-2
pubmed: 24252390
Colloids Surf B Biointerfaces. 2010 Jan 1;75(1):1-18
pubmed: 19782542
Adv Colloid Interface Sci. 2023 Mar;313:102848
pubmed: 36780780
Front Cell Dev Biol. 2023 Apr 10;11:1174043
pubmed: 37101615
J Nutr Biochem. 2014 Apr;25(4):363-76
pubmed: 24406273
AAPS J. 2017 Nov;19(6):1691-1702
pubmed: 29047044
Mater Sci Eng C Mater Biol Appl. 2017 Mar 1;72:168-176
pubmed: 28024573
Pharm Res. 2010 Sep;27(9):1759-71
pubmed: 20593303
Lancet Neurol. 2010 Jul;9(7):702-16
pubmed: 20610346
Ecotoxicol Environ Saf. 2020 Apr 1;192:110321
pubmed: 32061978
Eur J Med Chem. 2023 Jul 5;255:115382
pubmed: 37141706
Nat Mater. 2006 Feb;5(2):118-22
pubmed: 16444262
ACS Appl Mater Interfaces. 2022 Jan 26;14(3):3662-3674
pubmed: 35023712
Eur J Pharm Sci. 2017 May 1;102:180-187
pubmed: 28285172
Drug Deliv. 2011 Nov;18(8):555-61
pubmed: 21812752
Kidney Int. 2023 Jan;103(1):166-176
pubmed: 36341731
J Pharm Pharmacol. 2012 Mar;64(3):317-25
pubmed: 22309263
Neurology. 2000 Jun 27;54(12):2261-8
pubmed: 10881250
Mol Neurobiol. 2021 Jan;58(1):1-20
pubmed: 32889653
Acta Neuropathol. 2018 Jul;136(1):41-56
pubmed: 29934873
Alzheimers Dement (N Y). 2019 May 16;5:154-163
pubmed: 31193333
Adv Drug Deliv Rev. 2023 May;196:114816
pubmed: 37003488
ACS Biomater Sci Eng. 2017 Jul 10;3(7):1262-1272
pubmed: 33440514
Pharmaceutics. 2023 Jan 10;15(1):
pubmed: 36678859
Br J Psychiatry. 2005 Jul;187:90
pubmed: 15994581
Artif Cells Nanomed Biotechnol. 2018;46(sup3):S572-S584
pubmed: 30444141
Adv Mater. 2019 May;31(19):e1808303
pubmed: 30883982
Neural Plast. 2016;2016:8501693
pubmed: 26881137
Int J Biol Macromol. 2018 Oct 15;118(Pt A):1211-1219
pubmed: 30001606
Nanomedicine. 2011 Oct;7(5):521-40
pubmed: 21477665
Clin Anat. 1995;8(6):429-31
pubmed: 8713166
J Neurosci. 2008 Nov 5;28(45):11500-10
pubmed: 18987186
J Pharm Pharmacol. 2011 Mar;63(3):342-51
pubmed: 21749381
Int J Mol Sci. 2022 Dec 03;23(23):
pubmed: 36499562
Pharm Biol. 2023 Dec;61(1):135-143
pubmed: 36617895
Acta Pharm Sin B. 2021 Dec;11(12):4032-4044
pubmed: 35024324
Pharmacol Ther. 2012 Apr;134(1):8-25
pubmed: 22198801
Front Bioeng Biotechnol. 2022 May 30;10:919226
pubmed: 35711640
Adv Exp Med Biol. 2023;1394:181-192
pubmed: 36587388
Bioorg Chem. 2021 Feb;107:104535
pubmed: 33341280
J Pharm Pharmacol. 2019 Sep;71(9):1370-1383
pubmed: 31304982
Biomaterials. 2017 Nov;145:106-127
pubmed: 28865290
Drug Deliv Transl Res. 2018 Oct;8(5):1460-1470
pubmed: 29785574
Lancet Neurol. 2013 Apr;12(4):357-67
pubmed: 23477989
Curr Pharm Des. 2012;18(1):27-33
pubmed: 22211686
Nanomedicine (Lond). 2021 Oct;16(25):2249-2254
pubmed: 34544260
Neuron. 2008 Jan 24;57(2):178-201
pubmed: 18215617
Clin Cancer Res. 2008 Jul 1;14(13):4275-83
pubmed: 18594010
Vaccine. 2006 Sep 11;24(37-39):6321-31
pubmed: 16806604
J Am Chem Soc. 2004 Mar 10;126(9):2674-5
pubmed: 14995164
J Nucl Med. 2008 Nov;49(11):1875-83
pubmed: 18927326
Expert Opin Pharmacother. 2017 Apr;18(6):611-620
pubmed: 28300462
FASEB J. 2017 Aug;31(8):3383-3392
pubmed: 28420695
Crit Rev Ther Drug Carrier Syst. 2009;26(6):523-80
pubmed: 20402623
Brain Res Mol Brain Res. 1991 Sep;11(2):151-9
pubmed: 1661812
Neurochem Res. 2020 Sep;45(9):2161-2172
pubmed: 32583212
Nat Biotechnol. 2005 Mar;23(3):313-20
pubmed: 15765087
Acta Biomater. 2020 May;108:285-299
pubmed: 32251785
AAPS PharmSciTech. 2018 Nov;19(8):3698-3711
pubmed: 30238305
Theranostics. 2012;2(11):1037-9
pubmed: 23227120
J Mol Neurosci. 2022 Feb;72(2):173-186
pubmed: 34424488
ACS Omega. 2019 Jul 29;4(7):12833-12840
pubmed: 31460408
Acta Biomater. 2019 Mar 15;87:207-222
pubmed: 30716553
Reumatologia. 2017;55(6):269-275
pubmed: 29491534
Front Chem. 2021 Apr 23;9:580118
pubmed: 33981670
Adv Sci (Weinh). 2021 Feb 24;8(9):2004025
pubmed: 33977060
Nanomedicine. 2009 Mar;5(1):96-104
pubmed: 18693142
Int J Pharm. 2009 Jun 22;375(1-2):89-96
pubmed: 19481694
Clin Interv Aging. 2017 Apr 18;12:697-707
pubmed: 28458525
Expert Opin Drug Deliv. 2009 Oct;6(10):1017-32
pubmed: 19732031
Nanomicro Lett. 2019 Nov 16;11(1):100
pubmed: 34138027
J Alzheimers Dis. 2008 Mar;13(2):199-223
pubmed: 18376062
Part Fibre Toxicol. 2010 Mar 03;7:3
pubmed: 20199661
Neurology. 2007 Dec 11;69(24):2205-12
pubmed: 18071141
J Am Chem Soc. 2019 May 8;141(18):7235-7239
pubmed: 31010287
Front Cell Dev Biol. 2021 Aug 03;9:668491
pubmed: 34414179
Drug Des Devel Ther. 2016 Jan 12;10:205-15
pubmed: 26834457
ACS Pharmacol Transl Sci. 2020 Mar 26;3(3):472-488
pubmed: 32566913
Mater Today Bio. 2022 Oct 17;17:100463
pubmed: 36310541
Life Sci. 2018 Aug 15;207:428-435
pubmed: 29966606
N Engl J Med. 2012 Aug 30;367(9):795-804
pubmed: 22784036
Oncotarget. 2016 Oct 18;7(42):67716-67731
pubmed: 27626494
CNS Neurosci Ther. 2011 Oct;17(5):514-24
pubmed: 20553310
Neural Regen Res. 2018 May;13(5):930-935
pubmed: 29863025
J Drug Target. 2022 Jan;30(1):61-81
pubmed: 33983096
J Alzheimers Dis. 2019;70(2):573-585
pubmed: 31256130
Acta Pharm Sin B. 2022 Apr;12(4):1987-1999
pubmed: 35847512
J Drug Target. 2013 Apr;21(3):300-311
pubmed: 23231324
Alzheimers Dement. 2016 Apr;12(4):510-5
pubmed: 27103054
Int J Pharm. 2013 Mar 25;446(1-2):16-23
pubmed: 23410989
Invest Radiol. 2000 Aug;35(8):479-85
pubmed: 10946975
ACS Nano. 2023 Mar 14;17(5):5033-5046
pubmed: 36867454
Int J Nanomedicine. 2019 Jul 11;14:5159-5173
pubmed: 31371954
Nanomedicine (Lond). 2021 Feb;16(4):307-322
pubmed: 33501847
Immun Ageing. 2019 May 13;16:10
pubmed: 31114624
Molecules. 2022 Jan 04;27(1):
pubmed: 35011520
Pharm Res. 2019 Sep 16;36(11):161
pubmed: 31529284
Eur J Radiol. 2009 May;70(2):258-64
pubmed: 18995978
Int J Nanomedicine. 2018 Dec 12;13:8507-8522
pubmed: 30587974
Small. 2020 Jan;16(3):e1906273
pubmed: 31840420
Front Neurosci. 2020 Jun 09;14:494
pubmed: 32581676
Adv Pharm Bull. 2015 Sep;5(3):305-13
pubmed: 26504751
Chem Pharm Bull (Tokyo). 2010 May;58(5):656-61
pubmed: 20460792
Eur J Pharmacol. 2015 Jan 15;747:132-40
pubmed: 25449035
Int J Biol Macromol. 2019 Jun 1;130:515-526
pubmed: 30826404
ACS Nano. 2023 Feb 14;17(3):2222-2234
pubmed: 36688477
Int J Nanomedicine. 2016 Oct 18;11:5381-5414
pubmed: 27799765
Drug Deliv. 2016 May;23(4):1434-43
pubmed: 26405825
J Liposome Res. 2020 Dec;30(4):336-365
pubmed: 31558079
Int J Nanomedicine. 2015 Aug 04;10:4981-5003
pubmed: 26345528
Molecules. 2021 Oct 29;26(21):
pubmed: 34770940
Molecules. 2023 Jan 19;28(3):
pubmed: 36770702
IET Nanobiotechnol. 2023 May;17(3):154-170
pubmed: 36949020
Stem Cells Transl Med. 2020 Sep;9(9):1068-1084
pubmed: 32496649
Nutrients. 2016 Mar 15;8(3):167
pubmed: 26999194
Radiology. 2021 Mar;298(3):654-662
pubmed: 33399511
Eur J Pharm Sci. 2019 May 15;133:160-166
pubmed: 30914361
Langmuir. 2017 Jul 18;33(28):7118-7123
pubmed: 28654749
Nanoscale. 2019 Apr 11;11(15):7481-7496
pubmed: 30942233
Drug Deliv. 2017 Nov;24(1):692-700
pubmed: 28415883
Proc Natl Acad Sci U S A. 2011 Nov 15;108(46):18837-42
pubmed: 22065785
Front Aging Neurosci. 2009 Dec 09;1:4
pubmed: 20552055
J Alzheimers Dis. 2018;64(s1):S47-S105
pubmed: 29562524
Front Neurosci. 2023 Feb 24;17:1047778
pubmed: 36908787
Neurochem Int. 2013 Mar;62(4):458-67
pubmed: 23357480
Acta Pharm Sin B. 2016 Jul;6(4):268-86
pubmed: 27471668
Pharmaceutics. 2021 Jul 31;13(8):
pubmed: 34452143
J Biochem Pharmacol Res. 2013 Jun;1(2):84-90
pubmed: 23826514
Molecules. 2017 Feb 13;22(2):
pubmed: 28208831
Front Aging Neurosci. 2021 Nov 05;13:769506
pubmed: 34803660
Neuropharmacology. 2014 Jan;76 Pt A:27-50
pubmed: 23891641
Int J Nanomedicine. 2010 Feb 02;5:25-36
pubmed: 20161985
Neurobiol Learn Mem. 2019 Dec;166:107082
pubmed: 31493483
Int J Pharm. 2008 Jun 24;358(1-2):285-91
pubmed: 18455333
Free Radic Biol Med. 2005 Jun 15;38(12):1604-13
pubmed: 15917189
Cold Spring Harb Perspect Med. 2012 Jul;2(7):a006338
pubmed: 22762015
Acta Pharmacol Sin. 2008 Sep;29(9):1094-102
pubmed: 18718178
Ann N Y Acad Sci. 2017 Sep;1403(1):27-37
pubmed: 28675763
Alzheimers Dement (Amst). 2018 Aug 10;10:545-553
pubmed: 30370330
Curr Opin Biotechnol. 2003 Dec;14(6):659-64
pubmed: 14662398
Colloids Surf B Biointerfaces. 2015 Oct 1;134:88-97
pubmed: 26162977
Nat Biotechnol. 2018 Mar;36(3):258-264
pubmed: 29431737
Cold Spring Harb Perspect Med. 2012 May;2(5):a006270
pubmed: 22553493
Br J Pharmacol. 2012 Sep;167(2):324-52
pubmed: 22646481
Int J Hyperthermia. 2006 Jun;22(4):319-25
pubmed: 16754352
Alzheimers Dement. 2019 Jul;15(7):888-898
pubmed: 31164314
J Intern Med. 2014 Mar;275(3):251-83
pubmed: 24605808
J Control Release. 2016 Aug 10;235:34-47
pubmed: 27208862
Nanomedicine. 2016 Feb;12(2):421-30
pubmed: 26711963
J Nanobiotechnology. 2020 May 13;18(1):71
pubmed: 32404183
Biomaterials. 2021 Jan;267:120483
pubmed: 33129186
J Neurooncol. 2007 Jan;81(1):53-60
pubmed: 16773216
Nanomedicine. 2023 Apr;49:102662
pubmed: 36746272
Nanomedicine (Lond). 2023 Jan;18(2):109-123
pubmed: 36853798